News
4d
GlobalData on MSNCTO East Coast 2025: Navigating shifting regulatory environment hinges on close alignmentIn a more challenging regulatory environment for clinical trials, optimising trial designs early makes success more likely.
2d
Clinical Trials Arena on MSNAdapting to funding and operational hurdles in today’s clinical trials landscapeUK & Ireland, experts provided insights on market trends within the clinical trial industry and advice on engagement strategies.
Outdated regulations and inflexible sponsor processes are hampering clinical trial recruitment, but empowering sites with ...
Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 ...
Medically accredited supplement gains national traction with expert-backed multi-action formula and user trust.
This article discusses the complexities and challenges of transitioning clinical trials to comply with the EU Clinical Trial Regulation (CTR), offering insights and guidance to ensure a smooth ...
3d
Defense News on MSNPentagon trials drone-spotting air traffic suite at US bases worldwideThe Air Force Research Laboratory's CLUE system could help military and civil agencies better integrate drone operations into ...
3d
Vietnam Investment Review on MSNMedidata and University of Sydney Partner to Rethink Clinical TrialsMedidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, and the NHMRC Clinical Trials Centre (CTC) at the University of Sydney have ...
Professor Andrea Manfrin joined the MHRA in June 2023 as Deputy Director of Clinical Investigations and Trials, to spearhead the regulator’s overhaul of the clinical trial regulations. His ...
1don MSN
Discover how Masdar City in Abu Dhabi is at the forefront of autonomous vehicle technology with real-world testing of Level 4 ...
A remote dialectical behavior therapy program tailored to chronic pain significantly improved emotion regulation, according ...
A new analysis from US data analytics firm Phesi has raised concerns about the viability of ongoing Phase III trials in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results